[Home ] [Archive]    
Main Menu
Home::
Journal Information::
About the Journal
Editorial Board
Aims& Scopes
Journal News
Articles archive::
All Issues
Current Issue
For Authors::
Call for Papers
Submission Instruction
For Reviewers::
Reviewers Section
Subscription::
Registration Information
Subscription Form
Contact us::
Contact Information
Contact us
Site Facilities::
Site map
Search contents
FAQ
Top 10 contents
Inform to friends
Webmail::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 21, Issue 2 (jun-july 2016) ::
pajoohande 2016, 21(2): 58-60 Back to browse issues page
Control Group in Clinical trials: To have or not to have
Mahbobeh Oroei , Latif Gachkar *
, gachkar@sbmu.ac.ir
Abstract:   (4511 Views)

Abstract: 

Control group (s) is one of the most important criteria for the validity of clinical trials. This issue addresses the reasons for this and validity of non-control clinical trials.
Keywords: Control group, Clinical trails
Full-Text [PDF 136 kb]   (1171 Downloads)    
Type of Study: Original | Subject: Medicine
Received: 2017 | Accepted: 2017 | Published: 2017
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Oroei M, Gachkar L. Control Group in Clinical trials: To have or not to have. pajoohande 2016; 21 (2) :58-60
URL: http://pajoohande.sbmu.ac.ir/article-1-2170-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 21, Issue 2 (jun-july 2016) Back to browse issues page
Persian site map - English site map - Created in 0.05 seconds with 36 queries by YEKTAWEB 4660